Viewing and analyzing fine art from a medical perspective increases our appreciation of the artist’s suffering and teaches an important lesson of the human aspects of medicine. Paul Klee (1879–1940), one of the most influential artists of the 20th century, died at the age of 60 from complications of systemic sclerosis (scleroderma). In this second, in a series of clinical vignettes, I discuss the musculoskeletal manifestations of systemic sclerosis and how they may have influenced the life and art of Paul Klee.
KleeF. Paul Klee. New York: George Braziller, 1962.
2.
SilverRM. Paul Klee’s illness—a series of historical and clinical vignettes. J Scleroderma Relat Disord2017; 2(3): 135–136.
3.
OstendorfBMaiburgBSchneiderM. Sklerodermie und Paul Klee: metamorphose von Leben und Kunst. Z Rheumatol2004; 63: 318–325.
4.
SuterH. Paul Klee and His Illness. Basel: Karger AG, 2010.
5.
BaronMLeePKeystoneEC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis1982; 41(2): 147–152.
6.
MeierFMFrommerKWDinserR, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis2012; 71(8): 1355–1360.
7.
SuterH. Case report on the illness of Paul Klee (1879–1940). Case Rep Dermatol2014; 6(1): 108–113.
8.
WeiszGMAlburyWRMatucci-CerinicM. SSc and the 2013 diagnostic criteria: the case of Paul Klee’s manual pathology and dysgraphia. Clin Rheumatol2014; 33(11): 1671–1674.
9.
PrinceG. Art in a time of chronic illness: the effects of systemic sclerosis as seen through the works of Paul Klee. Pharos Alpha Omega Alpha Honor Med Soc2016; 79: 31–38.
10.
OppenheimL. A curious intimacy: art and neuro-psychoanalysis. New York: Routledge, 2005.
11.
WolfG. Endure! how Paul Klee’s illness influenced his art. Lancet1999; 353(9163): 1516–1518.
